In methods, compounds, and topical formulations for treatment of inflammatory skin disorders incorporating compounds represented by the formulas below:wherein each of R1, R2, and R3 is independently hydrogen, hologen, alkyl, or alkoxy； each of R4 and R5 is independently hydrogen, alkyl, or alkoxy； and each of R6 and R7 is independently hydrogen, nitro, alkyl, or alkoxy；wherein each of A1, A3, and A4 is independently hydrogen or alkyl； and A2 is independently hydrogen or hydroxy； andwherein each of B1, B2, and B3 is independently hydrogen, hydroxy, or alkoxy； and each of B4 and B5 is independently hydrogen or alkyl, applying such compounds topically as sprays, mists, aerosols, solutions, lotions, gels, creams, ointments, pastes, unguents, emulsions, and suspensions to treat inflammatory skin disorders and the symptoms associated therewith.
